RISING HEALTHCARE SPENDING PUSHES THE BUDGET BALANCE FURTHER IN THE RED
- Nova Scotia’s December 2025 forecast update revised the budget balance for fiscal year 2025–26 (FY26) to -$1.47 bn (-2.1% of nominal GDP) after accounting for contingencies (chart 1). The latest outlook sees a larger deficit for the current fiscal year, rising from -$0.9 bn (-1.4%) expected in Budget 2025–26, as higher departmental expenses outweigh higher revenue. The update also reports a $25 mn draw down from the $200 mn contingency funding set aside at the beginning of the fiscal year, with $175 mn in contingency remaining.
- Total expenses in the December 2025 update were revised higher by $722 mn (+4.1%) compared to Budget 2025–26. The increase in spending is largely concentrated in the departments of Health and Wellness (+$416.1 mn, +7%) and Seniors and Long-Term Care (+$83.5 mn, +5.7%), as increased utilization and inflationary pressures add to the province’s healthcare spending. There is also higher than previously forecasted spending on restructuring costs (+$172 mn, +31.2%) primarily due to corporate initiatives.
- Meanwhile, total revenue forecast for FY26 was revised up by $144 mn (+0.9%) compared to the Spring Budget. The revenue windfall is primarily owing to higher projected corporate income taxes (+$48.8 mn, +5.8%), federal transfers (+$57.5 mn, +1%), and positive prior year adjustments (+$82 mn). This is partially offset by reduced forecasts for personal income taxes (-$79.3 mn, -1.7%), due to lower-than-expected taxable income in 2024, and investment income (-$65 mn, -30.2%), primarily owing to an accounting adjustment change.
- There is no updated forecast for net debt (chart 2). However the larger deficit could reasonably push net debt levels higher. The forecast for nominal GDP growth in 2025 was left unchanged from the Spring Budget at 4.7%, while real GDP growth was lowered to 1.5% from 2% previously.
DISCLAIMER
This report has been prepared by Scotiabank Economics as a resource for the clients of Scotiabank. Opinions, estimates and projections contained herein are our own as of the date hereof and are subject to change without notice. The information and opinions contained herein have been compiled or arrived at from sources believed reliable but no representation or warranty, express or implied, is made as to their accuracy or completeness. Neither Scotiabank nor any of its officers, directors, partners, employees or affiliates accepts any liability whatsoever for any direct or consequential loss arising from any use of this report or its contents.
These reports are provided to you for informational purposes only. This report is not, and is not constructed as, an offer to sell or solicitation of any offer to buy any financial instrument, nor shall this report be construed as an opinion as to whether you should enter into any swap or trading strategy involving a swap or any other transaction. The information contained in this report is not intended to be, and does not constitute, a recommendation of a swap or trading strategy involving a swap within the meaning of U.S. Commodity Futures Trading Commission Regulation 23.434 and Appendix A thereto. This material is not intended to be individually tailored to your needs or characteristics and should not be viewed as a “call to action” or suggestion that you enter into a swap or trading strategy involving a swap or any other transaction. Scotiabank may engage in transactions in a manner inconsistent with the views discussed this report and may have positions, or be in the process of acquiring or disposing of positions, referred to in this report.
Scotiabank, its affiliates and any of their respective officers, directors and employees may from time to time take positions in currencies, act as managers, co-managers or underwriters of a public offering or act as principals or agents, deal in, own or act as market makers or advisors, brokers or commercial and/or investment bankers in relation to securities or related derivatives. As a result of these actions, Scotiabank may receive remuneration. All Scotiabank products and services are subject to the terms of applicable agreements and local regulations. Officers, directors and employees of Scotiabank and its affiliates may serve as directors of corporations.
Any securities discussed in this report may not be suitable for all investors. Scotiabank recommends that investors independently evaluate any issuer and security discussed in this report, and consult with any advisors they deem necessary prior to making any investment.
This report and all information, opinions and conclusions contained in it are protected by copyright. This information may not be reproduced without the prior express written consent of Scotiabank.
™ Trademark of The Bank of Nova Scotia. Used under license, where applicable.
Scotiabank, together with “Global Banking and Markets”, is a marketing name for the global corporate and investment banking and capital markets businesses of The Bank of Nova Scotia and certain of its affiliates in the countries where they operate, including; Scotiabank Europe plc; Scotiabank (Ireland) Designated Activity Company; Scotiabank Inverlat S.A., Institución de Banca Múltiple, Grupo Financiero Scotiabank Inverlat, Scotia Inverlat Casa de Bolsa, S.A. de C.V., Grupo Financiero Scotiabank Inverlat, Scotia Inverlat Derivados S.A. de C.V. – all members of the Scotiabank group and authorized users of the Scotiabank mark. The Bank of Nova Scotia is incorporated in Canada with limited liability and is authorised and regulated by the Office of the Superintendent of Financial Institutions Canada. The Bank of Nova Scotia is authorized by the UK Prudential Regulation Authority and is subject to regulation by the UK Financial Conduct Authority and limited regulation by the UK Prudential Regulation Authority. Details about the extent of The Bank of Nova Scotia's regulation by the UK Prudential Regulation Authority are available from us on request. Scotiabank Europe plc is authorized by the UK Prudential Regulation Authority and regulated by the UK Financial Conduct Authority and the UK Prudential Regulation Authority.
Scotiabank Inverlat, S.A., Scotia Inverlat Casa de Bolsa, S.A. de C.V, Grupo Financiero Scotiabank Inverlat, and Scotia Inverlat Derivados, S.A. de C.V., are each authorized and regulated by the Mexican financial authorities.
Not all products and services are offered in all jurisdictions. Services described are available in jurisdictions where permitted by law.